Reynolds picks
Raleigh to test Snus
Smokeless-tobacco pouches to
be sold as far as Greensboro
R.J. Reynolds Tobacco Co. has chosen
Raleigh as one of five new test markets for its Camel Snus smokeless
products, beginning July 1.
Camel Snus - pronounced “snooze” - comes
in a small pouch that is placed between the lip and gum. The tobacco
is pasteurized - not fermented - and it contains less moisture and
salt than moist snuff and does not require the consumer to spit, the
company said.
The Raleigh test market includes
convenience stores and tobacco-retail outlets as far west as the
eastern part of Greensboro, spokesman David Howard said yesterday.
Reynolds also has selected Columbus,
Ohio; Indianapolis; Kansas City, Mo.; and Orlando, Fla., as test
markets, according to Rob Dunham, a vice president of new-growth
innovation. The company has been testing the snus products in
Austin, Texas, and Portland, Ore., for more than a year.
“We’ve determined that Camel Snus is a
viable product concept that we will now make available in several
thousand retail outlets in the seven test markets,” Dunham said. He
said that Reynolds has not set a timetable for distributing and
marketing Camel Snus nationally.
Reynolds is not the only U.S. tobacco
manufacturer testing snus products.
Philip Morris USA Inc. said Friday that
it plans to introduce a Marlboro Snus product in August in the
Dallas/Fort Worth market. Philip Morris is testing Taboka
Tobaccopaks, which has drawn mixed reviews from consumers, according
to analysts.
“Philip Morris is trying to capitalize on
the growing popularity of smokeless products and the brand
importance of Marlboro in its snus products,” said Charles Norton, a
co-manager of the Vice Fund. The fund invests in the alcohol,
gaming, tobacco and aerospace-defense industries.
Both companies are focusing on smokeless
products as cigarette-smoking rates decline nationally and the
number of local and state smoking restrictions increase. The most
popular smokeless tobacco used is moist snuff, such as Kodiak and
Grizzly, two brands of Reynolds’ Conwood division.
Smokeless products are drawing support
from some anti-smoking groups as a less hazardous way to consume
tobacco. Those groups, as well as Reynolds, want any proposed
Federal Drug Administration regulation of tobacco products to allow
for the marketing of smokeless products as reduced risk compared
with cigarettes.
“Although
smokeless tobacco is just as addictive as cigarettes, and should not
be used by those who are not addicted to nicotine, cigarettes are
about 100 times deadlier than smokeless-tobacco products,”
said Bill Godshall, the executive director of SmokeFree
Pennsylvania.
“This is a key reason why Congress should
amend the proposed FDA tobacco regulatory legislation. The
legislation would require even larger misleading warnings on all
smokeless-tobacco products that state: ‘This product is not a safe
alternative to cigarettes,’ and would prohibit smokeless-tobacco
companies from truthfully claiming smokeless tobacco is a less
hazardous alternative to cigarettes.”
Other anti-smoking activists oppose
marketing smokeless tobacco under cigarettes’ brand names.
“It is no coincidence that these new
smokeless products are being introduced at the same time that states
are stepping up efforts to reduce tobacco use by implementing
smoke-free workplace laws, higher tobacco taxes, and tobacco
prevention and cessation programs,” said Vince Willmore, a vice
president of communications for the Campaign for Tobacco-Free Kids.
Tommy Payne, the executive vice president
of public affairs for Reynolds, said that “the growing body of
scientific evidence on the continuum risks of the use of cigarettes,
smokeless-tobacco products and other nicotine products requires
serious consideration, not unilateral dismissal, by Campaign for
Tobacco-Free Kids and others.”